Application of thin layer chromatography for the analytical diagnostics of combined prochlorperazine poisonings
DOI:
https://doi.org/10.24959/ophcj.20.195619Keywords:
prochlorperazine, poisoning, thin layer chromatography, chromogenic reagents, solvent systemsAbstract
The uncontrolled simultaneous application of prochlorperazine with typical phenothiazine derivatives antipsychotics and other drugs leads to fatal poisonings.
Aim. To optimize TLC procedures for the screening examinations in combined poisonings with prochlorperazine and other drugs.
Results and discussion. The chromatographic mobility of prochlorperazine, clorpromazine, ibuprofen, trifluoperazine and quetiapine has been studied on two types of plates (HPTLC and TLC). It has been shown that the TLC-systems used (special – for prochlorperazine, general – for screening of phenothiazine derivatives, as well as drug and narcotic substances of the basic nature recommended by the International Association of Forensic Toxicologists) rather effectively separate the substances analyzed in a thin layer of a sorbent, except for trifluoperazine. To detect the adsorption zones of substances, the Lieberman reagent giving different staining, the Dragendorff reagent and irradiation of chromatograms by UV-light (λ = 254 nm) have been proposed. The detection sensitivity is 0.5 – 1.0 μg in the sample. The validation assessment of the methods developed has been carried out by the chromatographic analysis of prochlorperazine model mixtures with each of the substances studied.
Experimental part. The studies were carried out on HPTLC plates (silica gel 60G, particle size – 5 – 7 μm, substrate type – glass, Estonia) with 10 × 10 cm in size and Merck plates (silica gel 60G F254, particle size – 10 – 15 μm, substrate type – aluminum foil, Germany) with 10 × 10 cm in size.
Conclusions. The TLC-conditions for screening of prochlorperazine, chlorpromazine, ibuprofen, trifluoperazin and quetiapine have been determined; they can be recommended for drugs detection in real samples of biological objects in the case of combined poisoning.
Received: 17.02.2020
Revised: 15.04.2020
Accepted: 29.05.2020
Supporting Agencies
- The themes of the Ministry of Public Health of Ukraine
- No. 0114U000958
Downloads
References
- Orr, S. L.; Friedman, B. W.; Christie, S.; Minen, M. T.; Bamford, C.; Kelley, N. E.; Tepper, D. Management of Adults with Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Headache 2016, 56 (6), 911–940. https://doi.org/10.1111/head.12835.
- Jaszczyszyn, A.; Gasiorowski, K.; Swiatek, P.; Malinka, W.; Cieslik-Boczula, K.; Petrus, J.; Czarnik-Matusewicz, B. Chemical structure of phenothiazines and their biological activity. Pharmacol. Rep. 2012, 64 (1), 16–23. https://doi.org/10.1016/S1734-1140(12)70726-0.
- Vertyneks. Kusum Kheltkhker. https://compendium.com.ua/info/220097/vertineks-sup-sup- (accessed 5 May 2020).
- Prochlorperazine. https://www.drugs.com/international/prochlorperazine.html (accessed 5 May 2020).
- Prochlorperazine. Dosage. https://www.drugs.com/dosage/prochlorperazine.html (accessed 5 May 2020).
- Merzlikin, S. I.; Kucher, T. V.; Stepanenko, V. I.; Pohosian, O. H. Analytical review of prochlorperazine side effects and acute poisonings. Ukr. Biopharm. J. 2019, 2 (59), 14–20. https://doi.org/10.24959/ubphj.19.214.
- Tanaka, E.; Nakamura, T.; Terada, M.; Shinozuka, T.; Hashimoto, C.; Kurihara, K.; Honda, K. Simple and simultaneous determination for 12 phenothiazines in human serum by reversed-phase high-performance liquid chromatography. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 854 (1–2), 116–120. https://doi.org/10.1016/j.jchromb.2007.04.004.
- Remezova I. P.; Lazaryan D. S.; Maksimenko T. I.; Sanzhieva D. Y.; Rybasova A. Y. Methods elaboration on detection of some atypical neurolytic agents for chemical and toxicological analysis. Pharmacy and Pharmacology 2014, 2 (6(7)), 54–58. https://doi.org/10.19163/2307-9266-2014-2-6(7)-54-58.
- Moffat A.C.; Osselton M.D.; Widdop B. Clarke’s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material. 4 ed.; Pharmaceutical Press: London, 2011.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
